Author
Listed:
- Brian D. Robinson
(Weill Cornell Medicine
Weill Cornell Medicine
Weill Cornell Medicine)
- Panagiotis J. Vlachostergios
(Weill Cornell Medicine)
- Bhavneet Bhinder
(Weill Cornell Medicine
Weill Cornell Medicine)
- Weisi Liu
(Weill Cornell Medicine)
- Kailyn Li
(Weill Cornell Medicine)
- Tyler J. Moss
(The University of Texas MD Anderson Cancer Center)
- Rohan Bareja
(Weill Cornell Medicine
Weill Cornell Medicine)
- Kyung Park
(Weill Cornell Medicine)
- Peyman Tavassoli
(Weill Cornell Medicine)
- Joanna Cyrta
(Weill Cornell Medicine
Weill Cornell Medicine)
- Scott T. Tagawa
(Weill Cornell Medicine
Weill Cornell Medicine
Weill Cornell Medicine
Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine)
- David M. Nanus
(Weill Cornell Medicine
Weill Cornell Medicine
Weill Cornell Medicine
Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine)
- Himisha Beltran
(Weill Cornell Medicine
Weill Cornell Medicine
Weill Cornell Medicine
Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine)
- Ana M. Molina
(Weill Cornell Medicine
Weill Cornell Medicine
Weill Cornell Medicine
Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine)
- Francesca Khani
(Weill Cornell Medicine
Weill Cornell Medicine
Weill Cornell Medicine)
- Juan Miguel Mosquera
(Weill Cornell Medicine
Weill Cornell Medicine
Weill Cornell Medicine)
- Evanguelos Xylinas
(Weill Cornell Medicine
Paris Descartes University)
- Shahrokh F. Shariat
(Weill Cornell Medicine
Medical University of Vienna)
- Douglas S. Scherr
(Weill Cornell Medicine)
- Mark A. Rubin
(Weill Cornell Medicine
Weill Cornell Medicine
Weill Cornell Medicine
Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine)
- Seth P. Lerner
(Baylor College of Medicine)
- Surena F. Matin
(The University of Texas MD Anderson Cancer Center)
- Olivier Elemento
(Weill Cornell Medicine
Weill Cornell Medicine
Weill Cornell Medicine
Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine)
- Bishoy M. Faltas
(Weill Cornell Medicine
Weill Cornell Medicine
Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine
Weill Cornell Medicine)
Abstract
Upper tract urothelial carcinoma (UTUC) is characterized by a distinctly aggressive clinical phenotype. To define the biological features driving this phenotype, we performed an integrated analysis of whole-exome and RNA sequencing of UTUC. Here we report several key insights from our molecular dissection of this disease: 1) Most UTUCs are luminal-papillary; 2) UTUC has a T-cell depleted immune contexture; 3) High FGFR3 expression is enriched in UTUC and correlates with its T-cell depleted immune microenvironment; 4) Sporadic UTUC is characterized by a lower total mutational burden than urothelial carcinoma of the bladder. Our findings lay the foundation for a deeper understanding of UTUC biology and provide a rationale for the development of UTUC-specific treatment strategies.
Suggested Citation
Brian D. Robinson & Panagiotis J. Vlachostergios & Bhavneet Bhinder & Weisi Liu & Kailyn Li & Tyler J. Moss & Rohan Bareja & Kyung Park & Peyman Tavassoli & Joanna Cyrta & Scott T. Tagawa & David M. N, 2019.
"Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling,"
Nature Communications, Nature, vol. 10(1), pages 1-11, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10873-y
DOI: 10.1038/s41467-019-10873-y
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Michiel S. Heijden & Thomas Powles & Daniel Petrylak & Ronald Wit & Andrea Necchi & Cora N. Sternberg & Nobuaki Matsubara & Hiroyuki Nishiyama & Daniel Castellano & Syed A. Hussain & Aristotelis Bamia, 2022.
"Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial,"
Nature Communications, Nature, vol. 13(1), pages 1-15, December.
- Kentaro Ohara & André Figueiredo Rendeiro & Bhavneet Bhinder & Kenneth Wha Eng & Hiranmayi Ravichandran & Duy Nguyen & David Pisapia & Aram Vosoughi & Evan Fernandez & Kyrillus S. Shohdy & Jyothi Mano, 2024.
"The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis,"
Nature Communications, Nature, vol. 15(1), pages 1-12, December.
- A. Gordon Robertson & Khyati Meghani & Lauren Folgosa Cooley & Kimberly A. McLaughlin & Leigh Ann Fall & Yanni Yu & Mauro A. A. Castro & Clarice S. Groeneveld & Aurélien Reyniès & Vadim I. Nazarov & V, 2023.
"Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer,"
Nature Communications, Nature, vol. 14(1), pages 1-19, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10873-y. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.